Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Systems analysis of ATF3 in stress response and cancer reveals opposing effects on pro-apoptotic genes in p53 pathway.

Tanaka Y, Nakamura A, Morioka MS, Inoue S, Tamamori-Adachi M, Yamada K, Taketani K, Kawauchi J, Tanaka-Okamoto M, Miyoshi J, Tanaka H, Kitajima S.

PLoS One. 2011;6(10):e26848. doi: 10.1371/journal.pone.0026848. Epub 2011 Oct 26.

2.

p53 Superfamily proteins in marine bivalve cancer and stress biology.

Walker CW, Van Beneden RJ, Muttray AF, Böttger SA, Kelley ML, Tucker AE, Thomas WK.

Adv Mar Biol. 2011;59:1-36. doi: 10.1016/B978-0-12-385536-7.00001-7. Review.

PMID:
21724017
3.

Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.

Engelmann D, Pützer BM.

Drug Resist Updat. 2010 Aug-Oct;13(4-5):119-31. doi: 10.1016/j.drup.2010.06.001. Epub 2010 Aug 1. Review.

PMID:
20675184
4.

p53: the attractive tumor suppressor in the cancer research field.

Ozaki T, Nakagawara A.

J Biomed Biotechnol. 2011;2011:603925. doi: 10.1155/2011/603925. Epub 2010 Dec 6. Review.

5.

ATF3 and stress responses.

Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U.

Gene Expr. 1999;7(4-6):321-35. Review.

PMID:
10440233
7.

Deconstructing p53 transcriptional networks in tumor suppression.

Bieging KT, Attardi LD.

Trends Cell Biol. 2012 Feb;22(2):97-106. doi: 10.1016/j.tcb.2011.10.006. Epub 2011 Dec 9. Review.

8.

The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate.

Eliaš J, Dimitrio L, Clairambault J, Natalini R.

Biochim Biophys Acta. 2014 Jan;1844(1 Pt B):232-47. doi: 10.1016/j.bbapap.2013.09.019. Epub 2013 Oct 8. Review.

PMID:
24113167
9.
10.

ATF3 transcription factor and its emerging roles in immunity and cancer.

Thompson MR, Xu D, Williams BR.

J Mol Med (Berl). 2009 Nov;87(11):1053-60. doi: 10.1007/s00109-009-0520-x. Epub 2009 Aug 25. Review.

11.

Tumor suppressive functions of p53.

Zilfou JT, Lowe SW.

Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a001883. doi: 10.1101/cshperspect.a001883. Review.

12.

Metabolic regulation by p53.

Maddocks OD, Vousden KH.

J Mol Med (Berl). 2011 Mar;89(3):237-45. doi: 10.1007/s00109-011-0735-5. Epub 2011 Feb 23. Review. Erratum in: J Mol Med. 2011 May;89(5):531.

13.

[Maintenance of hematopoietic stem cell integrity and regulation of leukemogenesis by p53 and its coactivator Aspp1].

Yamashita M, Nitta E, Suda T.

Rinsho Ketsueki. 2015 Dec;56(12):2426-33. doi: 10.11406/rinketsu.56.2426. Review. Japanese.

PMID:
26725350
14.

The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression.

Chen J.

Cold Spring Harb Perspect Med. 2016 Mar 1;6(3):a026104. doi: 10.1101/cshperspect.a026104. Review.

15.

The cytoplasmic side of p53's oncosuppressive activities.

Comel A, Sorrentino G, Capaci V, Del Sal G.

FEBS Lett. 2014 Aug 19;588(16):2600-9. doi: 10.1016/j.febslet.2014.04.015. Epub 2014 Apr 18. Review.

16.

The p53 network: cellular and systemic DNA damage responses in aging and cancer.

Reinhardt HC, Schumacher B.

Trends Genet. 2012 Mar;28(3):128-36. doi: 10.1016/j.tig.2011.12.002. Epub 2012 Jan 20. Review.

17.

The intersection between DNA damage response and cell death pathways.

Nowsheen S, Yang ES.

Exp Oncol. 2012 Oct;34(3):243-54. Review.

18.

Regulatory SNPs and transcriptional factor binding sites in ADRBK1, AKT3, ATF3, DIO2, TBXA2R and VEGFA.

Buroker NE.

Transcription. 2014;5(4):e964559. doi: 10.4161/21541264.2014.964559. Epub 2014 Oct 31. Review.

19.

Caught in the cross fire: p53 in inflammation.

Cooks T, Harris CC, Oren M.

Carcinogenesis. 2014 Aug;35(8):1680-90. doi: 10.1093/carcin/bgu134. Epub 2014 Jun 18. Review.

20.

Metabolic regulation by p53 family members.

Berkers CR, Maddocks OD, Cheung EC, Mor I, Vousden KH.

Cell Metab. 2013 Nov 5;18(5):617-33. doi: 10.1016/j.cmet.2013.06.019. Epub 2013 Aug 15. Review.

Supplemental Content

Support Center